"Not a reminder we love posting, but here it is again" ...

Namodenoson is an orally bioavailable A3 adenosine receptor (A3AR) agonist with anti-inflammatory and anti-fibrotic ...

In A Nutshell Johns Hopkins researchers developed a blood test that catches 81% of stage IA lung cancers (the earliest, most ...

On World Cancer Day, a cancer survivor examines how treating the mind alongside the tumour is finally becoming a critical ...

Yosemite, which funds startups and researchers working on the disease, is targeting a total of $350 million for its second fund from high-powered investors like pharma giant Amgen and hospital ...

Personal Perspective: "Normal" isn’t perfection but a statistical range based on population data. Diagnoses compare ...

A compound from ginger stops cancer cells from making fats and drains their energy, exposing a metabolic weakness in cancer cells.

"Nurses kept coming by to see him because usually people don't live through his specific type of break. He had to have a halo ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") , a biotechnology company focused on the treatment and prevention of cancer, today announced that the United States Adopted Names (USAN) Council ...

Katherine Haan, MBA, is a Senior Staff Writer for Forbes Advisor and a former financial advisor turned international bestselling author and business coach. For more than a decade, she’s helped small ...

Correcting inequalities in implementation of minimally invasive surgical resection has the potential to reduce inequalities in colon cancer outcomes.